These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Nonlinear pharmacokinetics and interconversion of prednisolone and prednisone in rats. Huang ML; Jusko WJ J Pharmacokinet Biopharm; 1990 Oct; 18(5):401-21. PubMed ID: 2266496 [TBL] [Abstract][Full Text] [Related]
27. Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy. Bartoszek M; Brenner AM; Szefler SJ Clin Pharmacol Ther; 1987 Oct; 42(4):424-32. PubMed ID: 3665340 [TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of Tedizolid in Plasma and Sputum of Adults with Cystic Fibrosis. Park AYJ; Wang J; Jayne J; Fukushima L; Rao AP; D'Argenio DZ; Beringer PM Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914949 [TBL] [Abstract][Full Text] [Related]
29. Cyclosporin pharmacokinetics in heart-lung transplant recipients with cystic fibrosis. Effects of pancreatic enzymes and ranitidine. Tsang VT; Johnston A; Heritier F; Leaver N; Hodson ME; Yacoub M Eur J Clin Pharmacol; 1994; 46(3):261-5. PubMed ID: 8070508 [TBL] [Abstract][Full Text] [Related]
30. A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma. Xu J; Winkler J; Derendorf H J Pharmacokinet Pharmacodyn; 2007 Jun; 34(3):355-72. PubMed ID: 17318442 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of amiloride after inhalation and oral administration in adolescents and adults with cystic fibrosis. Jones KM; Liao E; Hohneker K; Turpin S; Henry MM; Selinger K; Hsyu PH; Boucher RC; Knowles MR; Dukes GE Pharmacotherapy; 1997; 17(2):263-70. PubMed ID: 9085317 [TBL] [Abstract][Full Text] [Related]
32. [Pharmacokinetics of prednisolone in adrenal insufficiency ]. von Papen C; Benker G; Hackenberg K; Reinwein D Klin Wochenschr; 1982 Jul; 60(13):681-6. PubMed ID: 7120877 [TBL] [Abstract][Full Text] [Related]
33. Rapid methylprednisolone clearance in a patient with cystic fibrosis. Green CG; Kraus CK; Lemanske RF; Farrell PM; Jusko WJ Drug Intell Clin Pharm; 1988 Nov; 22(11):876-8. PubMed ID: 3234253 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic and Pharmacodynamic Analyses of Ceftaroline in Adults with Cystic Fibrosis. Autry EB; Rybak JM; Leung NR; Gardner BM; Burgess DR; Anstead MI; Kuhn RJ Pharmacotherapy; 2016 Jan; 36(1):13-8. PubMed ID: 26748559 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of netilmicin in children with and without cystic fibrosis. Michalsen H; Bergan T Antimicrob Agents Chemother; 1981 Jun; 19(6):1029-31. PubMed ID: 7271272 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of intravenous methylprednisolone and oral prednisone in paediatric patients with inflammatory bowel disease during the acute phase and in remission. Faure C; André J; Pelatan C; Munck A; Giraud M; Cèzard JP; Jacqz-Aigrain E Eur J Clin Pharmacol; 1998 Sep; 54(7):555-60. PubMed ID: 9832298 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of total and unbound prednisone and prednisolone in stable kidney transplant recipients with diabetes mellitus. Ionita IA; Ogasawara K; Gohh RY; Akhlaghi F Ther Drug Monit; 2014 Aug; 36(4):448-55. PubMed ID: 24452065 [TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics of ciprofloxacin in pediatric patients. Rajagopalan P; Gastonguay MR J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383 [TBL] [Abstract][Full Text] [Related]
39. Comparison of prednisolone kinetics in patients receiving daily or alternate-day prednisone for asthma. Greenberger PA; Chow MJ; Atkinson AJ; Ambre JJ; Patterson R Clin Pharmacol Ther; 1986 Feb; 39(2):163-8. PubMed ID: 3943272 [TBL] [Abstract][Full Text] [Related]
40. Steroid-specific effects of ketoconazole on corticosteroid disposition: unaltered prednisolone elimination. Ludwig EA; Slaughter RL; Savliwala M; Brass C; Jusko WJ DICP; 1989 Nov; 23(11):858-61. PubMed ID: 2596127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]